Research Article
Evaluation of Anxiety and Depression in Patients with Androgenetic Alopecia in Shanghai: A Cross-Sectional Study
Table 4
HADS scores of AGA patients and other dermatologic conditions.
| | Diseases | Total participants (N) | HADS-A
Mean (SD) | HADS-D
Mean (SD) |
| | Bullous pemphigoid [19] | 57 | 5.91 (2.30) | 7.77 (2.36) | | Chronic urticarial [20] | 79 | 5.8 (3.6) | 7.2 (3.6) | | Facial acne [21] | 60 | 11.00 (4.10) | 8.47 (3.03) | | HS [22] | 110 | 7 (4) | 6 (4) | | Rosacea [23] | 201 | 5.55 (3.82) | 4.84 (3.59) | | Vitiligo [24] | 37 | 7.5 (3.8) | 5.7 (4.3) | | Psoriasis [25] | 180 | 6.9 (4.2) | 4.7 (4.6) | | AD (mild) [26] | 536 | 5.5 (7.0) | 3.8 (3.7) | | AD (moderate) [26] | 513 | 7.3 (4.2) | 5.5 (3.9) | | AD (severe) [26] | 395 | 9.4 (4.1) | 8.2 (4.4) | | Scarring alopecia [15] | 19 (only female) | 8.3 (3.2) | 8.1 (2.7) | | Nonscarring alopecia [15] | 25 (only female) | 6.2 (2.0) | 5.4 (2.3) | | AGA (before treatment) [16] | 128 | 6.2 (3.17) | 4.0 (2.52) | | AGA (after treatment) [16] | 128 | 6.6 (3.06) | 4.6 (3.19) | | AGA | 192 | 6.12 (3.51) | 6.30 (2.44) |
|
|
Bold values are those derived from our study. 0‐7 is normal, 8‐10 is borderline, >10 is abnormal.
|
